Treating COVID-19 - Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials during Pandemics

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1897-1898
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	323
Issue number	19
DOIs	https://doi.org/10.1001/jama.2020.4742
State	Published - May 19 2020

ASJC Scopus subject areas

@article{948bb5c363944a8ba742052ba9e42e4a,

title = "Treating COVID-19 - Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials during Pandemics",

author = "Kalil, {Andre C.}",

year = "2020",

month = may,

day = "19",

doi = "10.1001/jama.2020.4742",

language = "English (US)",

volume = "323",

pages = "1897--1898",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "19",

}

TY - JOUR

T1 - Treating COVID-19 - Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials during Pandemics

AU - Kalil, Andre C.

PY - 2020/5/19

Y1 - 2020/5/19

UR - http://www.scopus.com/inward/record.url?scp=85082537970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082537970&partnerID=8YFLogxK

U2 - 10.1001/jama.2020.4742

DO - 10.1001/jama.2020.4742

M3 - Comment/debate

C2 - 32208486

AN - SCOPUS:85082537970

SN - 0098-7484

VL - 323

SP - 1897

EP - 1898

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 19

ER -